Itamar Medical Ltd (ITMMF) 0.3800 $ITMMF Itamar Medical

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Itamar Medical Ltd (ITMMF) 0.3800 $ITMMF

Itamar Medical Offers a Total Sleep Apnea Management Solution to Cardiologists
PR Newswire - Wed May 13, 8:00AM CDT
For the first time, the company will manage and coordinate all stages of diagnosis and treatment for hospitals

European Sleep Apnea Devices Market, by Segment, and Sleep Apnea Therapeutic Devices - Forecast to 2019
M2 - Wed May 06, 6:13AM CDT
Research and Markets (http://www.researchandmarkets.com/research/bjqw72/european_sleep) has announced the addition of the "European Sleep Apnea Devices Market, by Segment (Sleep Apnea Diagnostic Devices (Home Sleep Testing, Respiratory Polygraphs, Actigraphy Systems) and Sleep Apnea Therapeutic Devices (Pap Devices, Oxygen Devices, Airway Clearance Systems)-Forecast to 2019" report to their offering. The European sleep apnea devices market is projected to grow at a CAGR of 16.0% from 2014 to 2019 Germany holds the largest share of the European sleep apnea devices market. This large share of the German segment is attributed to the various driving forces, such as the increasing prevalence of sleep disorders in this region, increasing awareness level among patients and caregivers, rising number of cases of cardiovascular disorders, and the availability of technologically advanced diagnostic and therapeutic devices. However, the inadequate reimbursement coverage and patient compliance are perceived to hinder the growth of this market in the coming years. The high costs associated with the diagnosis and treatment of sleep apnea also restrains the growth of devices market in this region. The research report classifies the European sleep apnea devices market on the basis of segment into sleep apnea therapeutic devices and sleep apnea diagnostic devices. The sleep apnea therapeutic devices is further segmented based on types into home sleep testing/portable monitoring, sleep labs, respiratory polygraphs, two channel screening devices, single channel screening devices, and actigraphy systems. Similarly, the sleep apnea therapeutic devices market is segmented based on the types into Positive Airway Pressure (PAP) devices, masks, adaptive servo-ventilation, airway clearance systems, oxygen devices, and oral appliances. The PAP devices segment is the largest contributor in the therapeutic devices market. Moreover, the therapeutic devices segment is the largest contributor to the overall European sleep apnea devices market, having accounted for a share of 58.1% in 2014. Further, the European sleep apnea devices market is segmented based on the major countries of the region, such as Germany, France, the U.K., Italy, Spain, and the Rest of Europe (RoE). Germany is the largest market for sleep apnea devices in Europe. It accounted for a share of 27.9% of the European sleep apnea devices market in 2014. The major factors contributing to its dominance are the increasing prevalence of sleep disorders, rising awareness among patients and caregivers, and availability of advanced diagnosis and therapy options. France is the second-largest market in Europe and is projected to grow at a CAGR of 16.6% from 2014 to 2019. The U.K. houses the fastest-growing segment of the European sleep apnea devices market, and is projected to grow at the fastest CAGR from 2014 to 2019. The rising research & development activities pertaining to sleep disorders, rising obesity rates, and increasing awareness levels among patients and caregivers, are some of the factors expected to drive the growth of the European sleep apnea devices market in the coming years. Companies Mentioned - Ambulatory Monitoring, Inc. - BMC Medical Co., Ltd. - Carefusion Corporation - Compumedics Limited - Devilbiss Healthcare - Fisher and Paykel Healthcare Ltd. - Itamar Medical, Ltd. - Natus Medical, Inc. - Nihon Kohden - Nonin Medical - Philips Respironics (Subsidiary of Philips Healthcare Ltd.) - Resmed, Inc. - Somnomedics Gmbh - Weinmann Medical Devices Gmbh & Co. Kg For more information visit http://www.researchandmarkets.com/research/bj...pean_sleep
BABY: 39.17 (+0.48)

Sleep Apnea Devices Market by Segments (Sleep Apnea Therapeutic Devices, Sleep Apnea Diagnostic Devices) - Global Forecast to 2019
M2 - Thu Apr 23, 9:08AM CDT
Research and Markets (http://www.researchandmarkets.com/research/lnxd5m/sleep_apnea) has announced the addition of the "Sleep Apnea Devices Market by Segments (Sleep Apnea Therapeutic Devices, Sleep Apnea Diagnostic Devices) - Global Forecast to 2019" report to their offering. The global sleep apnea devices market is expected to grow at a CAGR of 16.6% during the forecast period of 2014 to 2019. North America is the largest market in the global sleep apnea devices market, with a market share of 51.8% as of 2013, followed by Europe and Asia. The largest share of the North American segment is associated with various driving forces, such as the increasing patient pool of sleep apnea in this region, increasing awareness level among patients and caregivers, and the availability of technologically advanced diagnostic and therapeutic devices. It is estimated that approximately 4% of men and 2% of women suffer from Obstructive Sleep Apnea (OSA) globally. Also, the rising prevalence of comorbidities (such as drug-resistant hypertension, congestive heart failure, Type 2 diabetes, and stroke, among others) ensures that the global sleep apnea patient pool will grow in the coming years. However, the inadequate reimbursement coverage and patient compliance are perceived to hinder the growth of this market during the forecast period, 2014 to 2019. In this report, the global sleep apnea devices market is broadly classified on the basis of segments, namely sleep apnea therapeutic devices and sleep apnea diagnostic devices. The sleep apnea therapeutic devices is further segmented based on types, into home sleep testing/portable monitoring, sleep labs, respiratory polygraphs, two-channel screening devices, single channel screening devices, and actigraphy systems. Similarly, the sleep apnea therapeutic devices market is segmented based on types, into Positive Airway Pressure (PAP) devices, masks, adaptive servo-ventilation, airway clearance systems, oxygen devices, and oral appliances. PAP devices segment is the highest contributor in the therapeutic devices market. Key Topics Covered: 1 Introduction 2 Research Methodology 3 Executive Summary 4 Market Overview 5 Global Sleep Apnea Devices Market, By Type 6 Global Sleep Apnea Market, By Geography 7 Global Sleep Apnea Devices Market: Competitive Landscape 8 Sleep Apnea Devices Market, By Company - Advanced Brain Monitoring,Inc., - Ambulatory Monitoring, Inc. - Bmc Medical Co., Ltd. - Cadwell Laboratories, Inc. - Carefusion Corporation - Clevemed - Compumedics Limited - Fisher And Paykel Healthcare Ltd. - Itamar Medical, Ltd. - Natus Medical, Inc. - Nihon Kohden - Nonin Medical - Novasom - Philips Respironics (Subsidiary Of Philips Healthcare Ltd.) - Resmed, Inc. - Weinmann Medical Devices Gmbh & Co. Kg For more information visit http://www.researchandmarkets.com/research/ln...leep_apnea
BABY: 39.17 (+0.48)

New Agreement Puts Itamar Medical Inc. and Arterial Health International on Track to Offer Greater Access to Innovative Cardiovascular Testing in the United States
PR Newswire - Mon Apr 20, 7:45AM CDT
Itamar Medical Inc., a subsidiary of Itamar Medical Ltd. (TASE: ITMR) and Arterial Health International LLC (AHI) announced today they have signed last month a representation agreement.

Global Sleep Apnea Diagnostic and Therapeutic Devices Market 2015-2019
M2 - Wed Apr 15, 4:23AM CDT
Research and Markets (http://www.researchandmarkets.com/research/8w259s/global_sleep) has announced the addition of the "Global Sleep Apnea Diagnostic and Therapeutic Devices Market 2015-2019" report to their offering. The Global Sleep Apnea Diagnostic and Therapeutic Devices market to grow at a CAGR of 8.16 percent over the period 2014-2019. Sleep apnea is a common sleeping disorder that breaks breath many times during sleep. OSA is the common type of sleep apnea, and it causes snoring, when the soft tissue in the back of the throat relaxes during sleep and blocks the airway. Sleep apnea symptoms includes morning headaches, waking up frequently to urinate, and dry mouth and sore in the morning. Sleep apnea diagnostic devices such PSG, actigraphy systems, and pulse oximeters are used for the screening of sleep apnea, while positive airway pressure and oral appliances are used for sleep apnea therapy. High adoption of home diagnostics for diagnosis of sleep apnea is a key trend ibn this market. Home diagnostics are convenient and cost-effective when compared to in-lab sleep tests and therefore are expected to propel the market growth. According to the report, high prevalence of sleep apnea disorder in people worldwide is a major driver in the market. The disorder is common in both adults and children and can result in hypertension, stroke, type II diabetes or adult onset diabetes, weight gain, impotence and cardiovascular diseases. Further, the report states that lack of patient compliance is a key challenges in the market. Discomfort coupled with nosebleeds, anxiety, appliance leaking, claustrophobia and nasal stuffiness contribute to non-compliance when using CPAP or BiPAP devices. Key Vendors - Fisher & Paykel Healthcare - Philips Healthcare - ResMed Other Prominent Vendors - Apnex Medical - Briggs Healthcare - Bunnell - Cadwell Laboratories - Carefusion - Clement Clarke International - Cleveland Medical Devices - Compumedics - Dehaier Medical Systems - DeVilbiss Healthcare - Drager Medical - Embla Systems - GE Healthcare - Hamilton Medical - ImThera Medical - Invacare Corporation - Itamar Medical - Natus Medical - Nihon Kohden - Salter Labs - Teleflex Medical - Ventus Medical - Weinmann Gerate fur Medizin - Zephyr Sleep Technologies Key Topics Covered: - Executive Summary - List of Abbreviations - Scope of the Report - Market Research Methodology - Introduction - Types of Sleep Apnea - Disease Linked with the Sleep Apnea - Symptoms Associated with Sleep Apnea - Market Landscape - Global Sleep Apnea Diagnostic and Therapeutic Devices Market - Geographical Segmentation - Buying Criteria - Market Growth Drivers - Drivers and their Impact - Market Challenges - Impact of Drivers and Challenges - Market Trends - Trends and their Impact - Vendor Landscape - Key Vendor Analysis For more information visit http://www.researchandmarkets.com/research/8w...obal_sleep
BABY: 39.17 (+0.48), DHRM: 1.40 (+0.07), IVC: 16.23 (-0.06)

Micro Market Monitor: North American Sleep Apnea Devices
M2 - Thu Dec 18, 6:15AM CST
Research and Markets (http://www.researchandmarkets.com/research/dnzfqg/micro_market) has announced the addition of the "Micro Market Monitor: North American Sleep Apnea Devices" report to their offering. The North American sleep apnea devices market is estimated to grow at a CAGR of 15.9% from 2014 to 2019. In 2013, the U.S. held the largest share in the North American sleep apnea devices market with 92.2%, followed by Canada. This market holds high growth potential in the future due to a number of forces favoring this market. These include the continuously growing base of sleep apnea patients, increasing awareness of sleep apnea and available diagnostic/therapeutic options, emerging popularity of oral appliances, and technological advancement. About 4% of men and 2% of women suffer from obstructive sleep apnea (OSA), globally. Due to rising obesity rates, the association of comorbidities such as drug-resistant hypertension, congestive heart failure, Type 2 diabetes, and stroke, the global sleep apnea patient pool is likely to grow in the years to come. However, dearth of reimbursement/insurance coverage and patient compliance seem to be hindering the growth of this market. In this report, the North American sleep apnea devices market is broadly classified into sleep apnea diagnostic devices and sleep apnea therapeutic devices. On the basis of products, the sleep apnea diagnostic devices market is further divided into home sleep testing/portable monitoring, traditional diagnostic (fixed PSG/in-lab PSG devices), respiratory polygraphs, two channel screening devices, single channel screening devices, and actigraphy systems. Key Topics Covered: 1 Executive Summary 2 Introduction 3 Market Overview 4 North American Sleep Apnea Devices Market, By Segment/Geography 5 Competitive Landscape 6 Company Profiles Companies Mentioned: - Advanced Brain Monitoring - Ambulatory Monitoring - Bmc Medical - Cadwell Laboratories - Carefusion Corporation - Clevemed - Compumedics - Fisher And Paykel Healthcare - Itamar Medical - Natus Medical - Nihon Kohden - Novasom - Philips Healthcare - Resmed - Weinmann Medical Devices Gmbh & Co For more information visit http://www.researchandmarkets.com/research/dn...cro_market
BABY: 39.17 (+0.48)

Sleep Apnea Diagnostic and Therapeutic Devices - 2014 Global Strategic Business Report
M2 - Thu Oct 30, 6:19AM CDT
Research and Markets (http://www.researchandmarkets.com/research/qbnnd7/sleep_apnea) has announced the addition of the "Sleep Apnea Diagnostic and Therapeutic Devices - Global Strategic Business Report" report to their offering. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Middle East & Africa, and Latin America. Annual estimates and forecasts are provided for the period 2013 through 2020. Also, a seven-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs. The report profiles 71 companies including many key and niche players such as: - Cadwell Laboratories, Inc. - CareFusion Corporation - Cleveland Medical Devices, Inc. - Compumedics Ltd. - DeVilbiss Healthcare - Global Medical Holdings LLC - Fisher & Paykel Healthcare Limited - GE Healthcare - Itamar Medical Ltd. - Invacare Corporation - Natus Medical Inc. - Embla Systems, Inc. - Grass Technologies - Philips Healthcare - ResMed Inc. - Teleflex Medical - Weinmann Ger?te f?r Medizin GmbH CCo. KG Key Topics Covered: I. Introduction, Methodology & Product Definitions II. Executive Summary 1. Market Overview 2. Market Trends And Dynamics 3. Sleep Apnea - A Synopsis 4. Sleep Apnea Diagnostic And Therapeutic Devices 5. Research Findings In Recent Past 6. Product Launches/Introductions 7. Recent Industry Activity 8. Focus On Select Players 9. Global Market Perspective III. Market 1. The United States 2. Canada 3. Japan 4. Europe 5. Asia-Pacific 6. Latin America 7. Middle East And Africa IV. Competitive Landscape Total Companies Profiled: 71 (including Divisions/Subsidiaries - 76) - The United States (48) - Canada (4) - Japan (1) - Europe (12) - - Germany (3) - - The United Kingdom (2) - - Italy (2) - - Spain (2) - - Rest of Europe (3) - Asia-Pacific (Excluding Japan) (8) - Middle East (3) For more information visit http://www.researchandmarkets.com/research/qb...leep_apnea
BABY: 39.17 (+0.48), IVC: 16.23 (-0.06), RMD: 54.30 (+0.39)

Respiratory Care Equipment and Supplies - 2014 Global Strategic Business Report
M2 - Tue Oct 28, 4:01AM CDT
Research and Markets (http://www.researchandmarkets.com/research/9qjvss/respiratory_care) has announced the addition of the "Respiratory Care Equipment and Supplies - Global Strategic Business Report" report to their offering. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Middle East, and Latin America. Annual estimates and forecasts are provided for the period 2013 through 2020. Also, a seven-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs. This report analyzes the worldwide markets for Respiratory Care Equipment and Supplies in US$ Thousands by the following Product Segments: - Spirometers - Other Pulmonary Function Testing (PFT) Equipment - Sleep Apnea Diagnostic Devices - Ventilators - Humidifiers - Nebulizers - PAP (positive airway pressure) - Devices - Oxygen Equipment - Manual Resuscitators - Masks - Circuits & Disposables The report profiles 148 companies including many key and niche players such as: - AirSep Corporation - Allied Healthcare Products, Inc. - CareFusion Corporation - Compumedics Limited - Covidien Ltd. - Dr?ger Medical AG & Co. KGaA - DeVilbiss Healthcare - Fisher & Paykel Healthcare Corporation Limited - GE Healthcare - Getinge Group - MAQUET GmbH & Co. KG - Hamilton Medical AG - Invacare Corporation - Itamar Medical Ltd. - nSpire Health, Inc. - Philips Healthcare - ResMed - VORTRAN Medical Technology - Weinmann Ger?te f?r Medizin GmbH CCo. KG Key Topics Covered: I. Introduction, Methodology & Product Definitions II. Executive Summary 1. Industry Overview 2. Respiratory Care Industry Classification 3. Competition In The Respiratory Care Market 4. Market Trends And Growth Drivers By Segment 5. Respiratory Diagnostics Equipment - A Review 6. Respiratory Therapy Equipment - A Review 7. Review Of Select Disease Conditions Requiring Respiratory Care 8. Pap Devices - The Largest Market Segment In Respiratory Care 9. Home Healthcare Market - A Broad Spectrum 10. Ventilators For Respiratory Care 11. Product Introductions/Innovations 12. Recent Industry Activity 13. Focus On Select Global Players 14. Global Market Perspective III. Market 1. The United States 2. Canada 3. Japan 4. Europe 5. Asia-Pacific 6. The Middle East 7. Latin America IV. Competitive Landscape Total Companies Profiled: 148 (including Divisions/Subsidiaries - 174) - The United States (78) - Canada (4) - Japan (9) - Europe (62) - - France (4) - - Germany (24) - - The United Kingdom (9) - - Italy (7) - - Spain (2) - - Rest of Europe (16) - Asia-Pacific (Excluding Japan) (15) - Latin America (1) - Middle East (5) For more information visit http://www.researchandmarkets.com/research/9q...atory_care
IVC: 16.23 (-0.06), COV: 106.71 (-1.36), AHPI: 1.18 (-0.02)

Galmed Pharmaceuticals and Itamar Medical to Collaborate on Assessing Aramchol's Effect on Endothelial Function
PR Newswire - Mon Sep 29, 8:13AM CDT
Galmed Pharmaceuticals Ltd. (Nasdaq: GLMD) ("Galmed" , a clinical-stage biopharmaceutical company focused on the development and commercialization of a once-daily, oral medication for the treatment of liver diseases and cholesterol gallstones, announced today that it purchased 60 EndoPAT(TM) devices and accessories from Itamar Medical Ltd. (TASE: ITMR) ("Itamar Medical" , a publicly-traded medical device company whose technology has been cleared by the U.S. Food and Drug Administration, or the FDA, for endothelial, or arterial, function assessment, which is a novel risk marker for cardiovascular disease.
GLMD: 9.01 (+0.12)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Flagship's £100M London Move to Ignite AI Ventures

Updated Category News Views 201

London Calling: Flagship's New Venture Flagship Pioneering, the brain behind bustling biotech ventures like Moderna, is planting its flag in London. They're launching Flagship Origination Lab, U.K., their first real gig outside good ol' Cambridge, Massachusetts. They're diving in headfirst, sprinkling a whopping £100 million to brew up AI-native platform companies. And...

Continue Reading
Bizzdesign Tops Gartner’s 2026 Enterprise Architecture List

Updated Category News Views 100

Enterprise Architecture’s Silent Backbone Sometimes it's the quiet operators like Bizzdesign that hijack the spotlight after years of steady steering. With the latest nod from Gartner, Bizzdesign is clearly on a tear in the enterprise architecture domain. In their 2026 Critical Capabilities report, Bizzdesign's products—Horizzon, Alfabet, and Hopex—secured top spots...

Continue Reading
PepsiCo Nears Deforestation-Free Sourcing Milestone by 2025

Updated Category News Views 129

PepsiCo's Aim for a Greener Supply Chain Well, look who's climbing the environmental ladder—PepsiCo. They’ve apparently hit 94% deforestation-free sourcing for those high-stakes commodities their empire relies on. Maybe it's a wake-up call for the rest of 'em still smogging about. The endgame? Full-fledged deforestation-free sourcing by 2030. That’s no walk in the...

Continue Reading
Priceline's Cyber Week: A Pocket-Friendly Travel Bonanza

Updated Category News Views 146

Unpacking Priceline's Cyber Week Bonanza Alright, folks, grab your booking hats because Priceline is back with its annual Cyber Week extravaganza, aiming to give travelers a shot in the arm of savings just when inflation has everyone pinching pennies. From November 16 through December 2, Priceline rolls out the red carpet for vacation planners, offering eye-popping...

Continue Reading
New York Reclaims Bagel Crown at 2026 BagelFest

Updated Category News Views 139

A Bagel Victory at Citi Field Holy schmear! New Yorker's are grinning wide like a bagel with a double helping of cream cheese—Ess-a-Bagel from Manhattan snagged the top honors at the heavily contested 2026 New York BagelFest. Back in its rightful hands, the Bagel Crown stays in the Empire State, and it's a victory for tradition and taste. Celebrating 50 years in the...

Continue Reading
Fortvita's Zybrivo Gains CHMP Nod: A European Leap

Updated Category News Views 103

It's not every day you're reading about a biotech making a ground-breaking shift off Chinese shores, but Fortvita's latest breakthrough is worth noting. Their fancy immunotherapy, Zybrivo® (sintilimab), just snagged a nod from the CHMP, Europe's committee that guides many on the medicinal merry-go-round. This isn't just your run-of-the-mill nod either. We're talking...

Continue Reading
YONDELIS: Thai Approval Opens New Sarcoma Treatment Path

Updated Category News Views 254

New Hope for Thai Sarcoma Patients Alright, we’ve got some good news coming out of Thailand, folks. The Thai FDA just greenlit YONDELIS® (trabectedin) for those grappling with advanced soft tissue sarcoma (STS). Now, this isn’t your everyday drug release—it’s a clinical chess move packing potential for patients who’ve run out of other options. December 1st,...

Continue Reading
Exploring Why Dead Outlets Stay Dead: Expert Insights

Updated Category News Views 66

The Mystery of Non-Responsive Outlets Ever found an electrical outlet refusing to cooperate when you need it most? Well, I know the frustration all too well. You'd think if the breaker ain't blown, the outlet should work like a charm. But dive into the guts of the story, and you find a series of surprises waiting to trip us up. Common Culprits: Tripped GFCIs and Loose...

Continue Reading
Baidu's Q3 2026: AI Explodes Amid Marketing Slump

Updated Category News Views 35

Baidu Looks to AI as Revenue Driver in Q3 2026 You know, Baidu's got one heck of a story this quarter. Despite some clouds hanging over them, they’ve managed to find a silver lining in their AI ventures. It’s like they’ve got this magic bullet with AI Cloud growth skyrocketing 94% year over year. That’s not just a rabbit outta the hat; it’s more like pulling a...

Continue Reading
MacKenzie-Childs Grinds Into Spotlight with Oprah's Nod

Updated Category News Views 50

Oprah's Golden Touch: 30 Years Strong Every year, there are a few select spots that brands covet like a hawk on a rabbit hunt. Getting on Oprah’s 'Favorite Things' list is surely one of them. Just like that, the MacKenzie-Childs Electric Salt and Pepper Grinder Set has muscled its way into the 2026 selection. Spare me the bells and whistles; this is like hitting the...

Continue Reading

Top 5 Most Recently Viewed Articles

Six Flags Stock Projects Continued Weakness Till 2027

Updated Category News Views 174

Understanding Six Flags Entertainment Corporation's Challenges Six Flags Entertainment Corporation (NYSE: FUN) has faced a significant decline in its stock value, showing signs of a challenging future in the realm of the Adhishthana Principles. As the company currently navigates through Phase 17 of its 18-phase Adhishthana cycle, the outlook for investors appears bleak,...

Continue Reading
BigBear.ai's Strategic Growth Following Strong Q3 Performance

Updated Category News Views 182

BigBear.ai's Stellar Surge Amid Q3 Results BigBear.ai Holdings (NYSE: BBAI) has recently captured the attention of investors with a notable surge in its stock, which rose nearly 19% to reach $6.79 in premarket trading. This increase follows a market close price of $5.71. The catalyst for this impressive rally stems from the artificial intelligence company’s robust...

Continue Reading
Innovative Security Solutions: AI-Enhanced Patrols for Safety

Updated Category News Views 227

Transforming Security with Technology In today's world, security is paramount. With concerns about safety and crime prevention evolving, companies are stepping forward to revolutionize traditional methods. One such transformation is being led by Safe Buildings, a prominent name in building management technology, in partnership with Pennine Security Solutions. This...

Continue Reading
Arconic Corporation Faces Class Action; Legal Insights Explained

Updated Category News Views 137

Overview of the Arconic Corporation Class Action Lawsuit Recent news reports have announced that a class action lawsuit has been initiated against Arconic Corporation (“Arconic” or the “Company”), a significant player in the manufacturing sector, particularly known for its aluminum products. The lawsuit centers around allegations of securities fraud and other...

Continue Reading
Globe Life Inc.: Fourth Quarter 2024 Financial Overview

Updated Category News Views 174

Overview of Globe Life Inc.'s Fourth Quarter 2024 Performance Globe Life Inc. (NYSE: GL) recently released its financial results for the quarter ending December 31, 2024. The company reported significant growth in its net income and operating income, highlighting a robust financial health and effective operational strategies. Key Financial Highlights In this quarter,...

Continue Reading